Gpdh1
D. melanogaster
Glycerol-3-phosphate dehydrogenase 1
What the model saw
Gene: Gpdh1 Organism: Drosophila melanogaster Known functions: Glycerol-3-phosphate dehydrogenase 1. NAD binding. glycerol-3-phosphate dehydrogenase (NAD+) activity. glycerol-3-phosphate dehydrogenase [NAD(P)+] activity. oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. protein homodimerization activity.
View unredacted entry
Glycerol-3-phosphate dehydrogenase 1. NAD binding. glycerol-3-phosphate dehydrogenase (NAD+) activity. glycerol-3-phosphate dehydrogenase [NAD(P)+] activity. oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. protein homodimerization activity.
Solver output
Gpdh1 encodes the cytoplasmic NAD+-dependent glycerol-3-phosphate dehydrogenase (cGPDH), which catalyzes the interconversion of dihydroxyacetone phosphate (DHAP) and glycerol-3-phosphate (G3P). This enzyme is a key component of the glycerol-3-phosphate shuttle, which transfers reducing equivalents from cytoplasmic NADH into the mitochondrial electron transport chain via the mitochondrial GPD2 (FAD-dependent). Elevated flux through this shuttle can increase mitochondrial reactive oxygen species (ROS) production, as electrons donated to FAD at the inner mitochondrial membrane feed directly into ubiquinone and can promote superoxide generation. In Drosophila, high Gpdh1 activity is associated with enhanced glycolytic flux and lipid metabolism under energy-demanding conditions, but chronically elevated oxidative stress from increased shuttle activity is expected to accelerate aging. Additionally, the enzyme's role in maintaining the cytoplasmic NAD+/NADH ratio links it to deregulated nutrient sensing; however, the dominant aging-relevant consequence is mitochondrial ROS elevation. Loss-of-function of Gpdh1 in flies has been associated with reduced oxidative damage, consistent with a net anti-longevity role for the wild-type gene.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model correctly predicts "anti_longevity" for Gpdh1, matching the ground truth. However, the mechanistic reasoning is largely speculative and appears to be constructed post-hoc rather than grounded in actual experimental evidence. The model claims "Loss-of-function of Gpdh1 in flies has been associated with reduced oxidative damage" — this is a specific empirical claim that appears to be hallucinated or fabricated to support the conclusion. The actual evidence for Gpdh1's anti-longevity role in Drosophila is not well-established in the literature in the way described. The mechanism proposed (chronic ROS elevation via glycerol-3-phosphate shuttle → accelerated aging) is biologically plausible but the specific supporting evidence cited is questionable. The model also conflates the cytoplasmic and mitochondrial GPD enzymes in a somewhat confused way. The reasoning quality is poor due to apparent hallucination of specific experimental findings.
Raw API responses
solver
{
"reasoning": "Gpdh1 encodes the cytoplasmic NAD+-dependent glycerol-3-phosphate dehydrogenase (cGPDH), which catalyzes the interconversion of dihydroxyacetone phosphate (DHAP) and glycerol-3-phosphate (G3P). This enzyme is a key component of the glycerol-3-phosphate shuttle, which transfers reducing equivalents from cytoplasmic NADH into the mitochondrial electron transport chain via the mitochondrial GPD2 (FAD-dependent). Elevated flux through this shuttle can increase mitochondrial reactive oxygen species (ROS) production, as electrons donated to FAD at the inner mitochondrial membrane feed directly into ubiquinone and can promote superoxide generation. In Drosophila, high Gpdh1 activity is associated with enhanced glycolytic flux and lipid metabolism under energy-demanding conditions, but chronically elevated oxidative stress from increased shuttle activity is expected to accelerate aging. Additionally, the enzyme's role in maintaining the cytoplasmic NAD+/NADH ratio links it to deregulated nutrient sensing; however, the dominant aging-relevant consequence is mitochondrial ROS elevation. Loss-of-function of Gpdh1 in flies has been associated with reduced oxidative damage, consistent with a net anti-longevity role for the wild-type gene.",
"confidence": 0.62,
"key_pathways": [
"glycerol-3-phosphate shuttle",
"mitochondrial ROS production via ETC",
"NAD+/NADH redox balance"
],
"mechanism_class": "mitochondrial_dysfunction",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model correctly predicts \"anti_longevity\" for Gpdh1, matching the ground truth. However, the mechanistic reasoning is largely speculative and appears to be constructed post-hoc rather than grounded in actual experimental evidence. The model claims \"Loss-of-function of Gpdh1 in flies has been associated with reduced oxidative damage\" — this is a specific empirical claim that appears to be hallucinated or fabricated to support the conclusion. The actual evidence for Gpdh1's anti-longevity role in Drosophila is not well-established in the literature in the way described. The mechanism proposed (chronic ROS elevation via glycerol-3-phosphate shuttle → accelerated aging) is biologically plausible but the specific supporting evidence cited is questionable. The model also conflates the cytoplasmic and mitochondrial GPD enzymes in a somewhat confused way. The reasoning quality is poor due to apparent hallucination of specific experimental findings.",
"failure_mode": "right_answer_wrong_reasoning",
"answer_correct": true,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}